GlaxoSmithKline Pharmaceuticals Limited Share Price NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Market Closed -
NSE India S.E.
04:35:08 18/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,877.40 INR | +6.46% |
|
+10.59% | +16.32% |
| 03/08 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 03/08 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 49TCr 509.77Cr 440.29Cr 414.26Cr 376.5Cr 708.14Cr 718.52Cr 4.86TCr 1.9TCr 24TCr 1.91TCr 1.87TCr 81TCr | P/E 2027 * |
42.1x | P/E 2028 * | 36.6x |
|---|---|---|---|---|---|
| Enterprise Value | 49TCr 509.77Cr 440.29Cr 414.26Cr 376.5Cr 708.14Cr 718.52Cr 4.86TCr 1.9TCr 24TCr 1.91TCr 1.87TCr 81TCr | EV / Sales 2027 * |
11.5x | EV / Sales 2028 * | 10.4x |
| Free-Float |
-
| Yield 2027 * |
1.02% | Yield 2028 * | 1.02% |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | +6.46% | ||
| 1 week | +10.59% | ||
| Current month | +8.36% | ||
| 1 month | +17.22% | ||
| 3 months | +20.40% | ||
| 6 months | +11.36% | ||
| Current year | +16.32% |
| 1 week | 2,606.4 |  | 2,919 |
| 1 month | 2,445.4 | | 2,919 |
| Current year | 2,088.1 | | 2,919 |
| 1 year | 2,088.1 | | 2,919 |
| 3 years | 1,385.05 | | 3,515.7 |
| 5 years | 1,227 | | 3,515.7 |
| 10 years | 962.65 | | 3,515.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 01/12/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 01/04/2026 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 73 | 01/04/2019 |
| Director/Board Member | 59 | 18/05/2020 | |
Manu Anand
BRD | Director/Board Member | 67 | 16/05/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.46% | +10.59% | - | - | 478.35Cr | |
| +3.60% | +0.88% | +75.59% | +124.32% | 1,05500Cr | |
| +3.33% | +4.35% | +53.82% | +57.17% | 63TCr | |
| +3.43% | +3.53% | +25.34% | +72.45% | 44TCr | |
| +1.35% | -2.17% | +40.98% | +41.50% | 35TCr | |
| +1.75% | -0.24% | +25.28% | +40.46% | 29TCr | |
| +2.13% | -0.32% | +0.58% | +10.77% | 24TCr | |
| +1.41% | +2.65% | +45.34% | +62.43% | 23TCr | |
| +1.35% | -3.53% | -14.72% | -52.63% | 20TCr | |
| +3.25% | +5.65% | +21.57% | +89.04% | 17TCr | |
| Average | +2.81% | +0.10% | +30.42% | +49.50% | 40.14TCr | |
| Weighted average by Cap. | +2.79% | +0.23% | +43.70% | +68.42% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4.25TCr 44Cr 38Cr 36Cr 33Cr 62Cr 63Cr 423.1Cr 165.81Cr 2.13TCr 166.65Cr 163.03Cr 7.08TCr | 4.72TCr 49Cr 43Cr 40Cr 36Cr 68Cr 69Cr 469.25Cr 183.9Cr 2.36TCr 184.83Cr 180.81Cr 7.86TCr |
| Net income | 1.16TCr 12Cr 10Cr 9.85Cr 8.95Cr 17Cr 17Cr 115.52Cr 45Cr 580.71Cr 45Cr 45Cr 1.93TCr | 1.34TCr 14Cr 12Cr 11Cr 10Cr 19Cr 20Cr 132.95Cr 52Cr 668.38Cr 52Cr 51Cr 2.23TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | ₹2,877.40 | +6.46% | 4,77,841 |
| 17/26/17 | ₹2,702.90 | +0.52% | 84,337 |
| 14/26/14 | ₹2,688.80 | +0.79% | 94,952 |
| 13/26/13 | ₹2,667.70 | +1.81% | 59,367 |
| 12/26/12 | ₹2,620.20 | +0.70% | 64,718 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 500660 Stock
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
